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Estimating the Effect of Palliative Care Interventions and Advance Care
Planning on ICU Utilization: A Systematic Review
Abstract

OBJECTIVE: We conducted a systematic review to answer three questions: 1) Do advance care planning and
palliative care interventions lead to a reduction in ICU admissions for adult patients with life-limiting
illnesses? 2) Do these interventions reduce ICU length of stay? and 3) Is it possible to provide estimates of the
magnitude of these effects?
DATA SOURCES: We searched MEDLINE, EMBASE, Cochrane Controlled Clinical Trials, and Cumulative
Index to Nursing and Allied Health Literature databases from 1995 through March 2014.
STUDY SELECTION: We included studies that reported controlled trials (randomized and nonrandomized)
assessing the impact of advance care planning and both primary and specialty palliative care interventions on
ICU admissions and ICU length of stay for critically ill adult patients.
DATA EXTRACTION: Nine randomized controlled trials and 13 nonrandomized controlled trials were
selected from 216 references.
DATA SYNTHESIS: Nineteen of these studies were used to provide estimates of the magnitude of effect of
palliative care interventions and advance care planning on ICU admission and length of stay. Three studies
reporting on ICU admissions suggest that advance care planning interventions reduce the relative risk of ICU
admission for patients at high risk of death by 37% (SD, 23%). For trials evaluating palliative care
interventions in the ICU setting, we found a 26% (SD, 23%) relative risk reduction in length of stay with these
interventions.
CONCLUSIONS: Despite wide variation in study type and quality, patients who received advance care
planning or palliative care interventions consistently showed a pattern toward decreased ICU admissions and
reduced ICU length of stay. Although SDs are wide and study quality varied, the magnitude of the effect is
possible to estimate and provides a basis for modeling impact on healthcare costs.
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Abstract
Objective—We conducted a systematic review to answer three questions: 1) Do advance care
planning and palliative care interventions lead to a reduction in ICU admissions for adult patients
with life-limiting illnesses? 2) Do these interventions reduce ICU length of stay? and 3) Is it
possible to provide estimates of the magnitude of these effects?
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Data Sources—We searched MEDLINE, EMBASE, Cochrane Controlled Clinical Trials, and
Cumulative Index to Nursing and Allied Health Literature databases from 1995 through March
2014.
Study Selection—We included studies that reported controlled trials (randomized and
nonrandomized) assessing the impact of advance care planning and both primary and specialty
palliative care interventions on ICU admissions and ICU length of stay for critically ill adult
patients.
Data Extraction—Nine randomized controlled trials and 13 nonrandomized controlled trials
were selected from 216 references.
Data Synthesis—Nineteen of these studies were used to provide estimates of the magnitude of
effect of palliative care interventions and advance care planning on ICU admission and length of
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stay. Three studies reporting on ICU admissions suggest that advance care planning interventions
reduce the relative risk of ICU admission for patients at high risk of death by 37% (SD, 23%). For
trials evaluating palliative care interventions in the ICU setting, we found a 26% (SD, 23%) relative
risk reduction in length of stay with these interventions.
Conclusions—Despite wide variation in study type and quality, patients who received advance
care planning or palliative care interventions consistently showed a pattern toward decreased ICU
admissions and reduced ICU length of stay. Although SDs are wide and study quality varied, the
magnitude of the effect is possible to estimate and provides a basis for modeling impact on
healthcare costs.
Keywords
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advance care planning; critical care; end-of-life; intensive care unit utilization; length of stay;
palliative care
In the United States, a significant proportion of healthcare resources are spent on care for
critically ill patients. In 2005, critical care costs were estimated to be $82 billion, accounting
for 13% of inpatient hospital costs (1, 2). The United States spends more hospital resources
on critical care than any other country, as evidenced by the highest ratios of ICU bed-topopulation (20 ICU beds per 100K people) and ICU-to-hospital bed (nine ICU beds per 100
hospital beds) in the world (2). Furthermore, a significant and rising portion of these
expenses are for patients who die. According to a study of Medicare claims data, ICU use in
the last 30 days of life increased 5% between 2000 and 2009 (3).
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Importantly, these high-technology treatments may not be targeting outcomes that are
consistent with patient values and preferences (4). Interventions that clarify patients’ goals
of care and whether ICU care is consistent with these goals may reduce the intensity of endof-life care. For example, ICU admissions and length of stay (LOS) may be reduced by
ensuring that patients do not receive unwanted ICU care; such interventions may incorporate
diverse approaches including advance care planning, palliative care consultation, or ethics
consultation (4–8). Systematic reviews (5, 9) of the impact of advance care planning or
palliative care or ethics interventions on ICU resource utilization suggest decreases in
resource utilization. However, none have included interventions both before and in the ICU
setting, including primary and specialty palliative care, and none have estimated the
magnitude of effects on ICU admission and LOS. Importantly, the primary reason for
implementing palliative care should be to improve quality of care and patient and family
outcomes. Nonetheless, estimates of the magnitude of these effects may be used for future
studies modeling the potential impact of such interventions on healthcare costs (10, 11) and
may inform future interventions and policy development.
We conducted a systematic review to answer the following questions: 1) Do advance care
planning interventions lead to a reduction in ICU admissions for adult patients with lifelimiting illnesses when compared to usual care? 2) Do advance care planning and palliative
care interventions reduce ICU LOS in this population when compared to usual care? and 3)
Is it possible to provide estimates of the magnitude of these effects?
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METHODS
Data Sources
This systematic review includes published controlled trials (randomized and
nonrandomized) reporting on the effect of advance care planning and palliative care
interventions on ICU admissions and ICU LOS. We refer to ICU admissions and ICU LOS
as “ICU utilization.” We excluded studies published prior to 1995 because of the impact the
landmark Study to Understand Prognoses and Preferences for Outcomes and Risks of
Treatments trial had on end-of-life care (12). We searched MEDLINE, EMBASE, Cochrane
Controlled Clinical Trials, and Cumulative Index to Nursing and Allied Health Literature
databases from 1995 through March 2014. In addition, we reviewed reference lists.
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We defined relevant interventions as inclusive of advance care planning, primary palliative
care (palliative care or communication interventions provided by nonpalliative care
specialists such as family meetings), specialty palliative care (palliative care provided by
palliative care specialists), and ethics consultation that include a focus on communication
about the goals of care. We included interventions conducted in the outpatient, acute care,
and ICU settings. We focused on adults (age ≥ 18) because interventions and outcomes in
the neonatal ICU and PICU are likely to be very different.
Search Terms
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Our search strategy used a list of terms grouped under three main subject headings:
palliative care AND intensive care AND resource utilization (full list of search terms in eTable 1, Supplemental Digital Content 1, http://links.lww.com/CCM/B162). A research
librarian at the University of Washington Health Sciences library assisted with development
and execution of our search strategy.
Study Selection, Data Extraction, and Quality Assessment
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Two researchers independently screened all titles and reviewed selected abstracts and fulltext articles (N.K., E.K.K.: practicing intensivists and researchers focusing on palliative
care). Both researchers also independently extracted quantitative and other critical data from
included studies. All titles were reviewed. Titles were excluded on the basis of four criteria:
1) no specific focus on palliative or end-of-life care, 2) no relevance to ICU utilization, 3)
editorials or narrative reviews, or 4) focus exclusively on pediatric populations. Abstracts for
the retained titles were reviewed, and the full-text article was retrieved for any abstract
considered potentially relevant. In the full review, we retained articles that met the following
criteria: 1) adult patient population, 2) randomized controlled trials (RCTs) or
nonrandomized controlled trials (non-RCTs), and 3) ICU LOS and/or ICU admission
included as an outcome.
Data from selected articles were abstracted using a standardized instrument. A quality
checklist was created using previously reported quality metrics (5) and recommendations
from the Consolidated Standards for Reporting Trials group (13, 14). In addition, criteria for
non-RCTs from the Transparent Reporting of Evaluations with Nonrandomized Designs
were included (15). Our final quality metric checklist is a modified version of a previously
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used checklist and included type of controls, determination of sample size, data quality,
prespecification of outcome measures, and intervention adherence (5).
Data Synthesis and Analysis
Studies selected for inclusion were grouped by our outcomes— ICU admissions and ICU
LOS; within these subgroups, studies were further grouped by RCTs and non-RCTs. For
trials reporting LOS, studies were additionally categorized by intervention setting.
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In order to estimate the magnitude of effect of advance care planning and palliative care
interventions on ICU utilization, we calculated the mean relative risk reduction of ICU
admission and ICU LOS for each study, when applicable. We then aggregated these values
and determined the mean relative risk reduction in ICU admission and ICU LOS among all
relevant studies. For ICU LOS, we categorized studies according to the setting in which the
intervention took place and provided separate estimates for interventions taking place in the
ICU, acute care, and outpatient settings.
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When calculating LOS estimates, we excluded five studies for the following reasons: 1) two
studies where intervention setting was not clear (16, 17); 2) one study not designed to study
the effect of the intervention on resource utilization because patients were recruited if
expected to die within a few days (18); 3) one study with a very small sample size (n =
10/2009 eligible) (19); and 4) one study confounded by indication bias that did not report
adjusted estimates (20). For studies that reported separate estimates for decedents (21, 22),
we included estimates for decedents in the primary analysis because the primary mechanism
of action for reducing ICU LOS is likely to be earlier decisions to limit life-sustaining
therapies for patients who will die irrespective of duration of life-sustaining therapy. We
conducted sensitivity analyses using results for survivors and the entire cohort and found
results were similar. These data have been included in e-Table 2 (Supplemental Digital
Content 2, http://links.lww.com/CCM/B163).

RESULTS
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A total of 216 articles were identified; 44 duplicates were excluded, leaving 172 titles to be
screened. Title review led to the exclusion of 131 articles. Of the 42 remaining abstracts and
eight additional abstracts identified by hand-searching reference lists, full-text articles were
retrieved for 36 studies. Of these 36 articles, 22 met our inclusion criteria (Fig. 1). All 22
studies compared an advance care planning or palliative care intervention (as defined above)
to usual care in adult patient populations with ICU admissions and/or ICU LOS as an
outcome. Results of the overall methodological quality are displayed in Tables 1 and 2. A
variety of interventions at the patient or system level were studied. Although patient
populations varied, all were patients considered to be at high risk of death. Studies included
in estimating the magnitude of intervention effects are listed in Tables 3 and 4.
Heterogeneity in study interventions, study design, and study populations precluded us from
conducting a quantitative meta-analysis.

Crit Care Med. Author manuscript; available in PMC 2016 May 01.
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For all studies with ICU admissions as an outcome, the intervention was focused at the
patient level (Tables 1 and 3).
RCTs—In a multicenter RCT, Gade et al (23) examined the effect of routine palliative care
consultation among hospitalized patients and reported future ICU admissions as an outcome.
In this trial, 275 patients hospitalized with a life-limiting illness received the intervention;
237 received usual care. Patients receiving the palliative care intervention had fewer ICU
admissions upon subsequent hospital admission (5% vs 10% in usual care; relative risk
reduction for all patients 50%; p = 0.04).
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Non-RCTs—Penrod et al (16) conducted two retrospective observational studies evaluating
the impact of palliative care consultation on ICU admissions. In the first study, published in
2006 and including consecutive veterans who died after hospitalization greater than 3 days,
33% of patients receiving a palliative care consultation had an ICU admission compared to
68% of patients receiving usual care (p < 0.001). Using multivariate probit regression to
adjust for patient characteristics, the authors found an adjusted risk reduction of 42% (95%
CI, −56%, −31%) in ICU admissions for patients who received a palliative care consultation.
A subsequent, larger retrospective study consisting of 3,321 veterans hospitalized with
advanced disease found that patients receiving palliative care consultation had an adjusted
risk reduction of being admitted to the ICU during the same hospitalization of 44% (95% CI,
49%, 39%; p < 0.001) (17). In this cohort, including both survivors and decedents, 33% of
hospitalizations for patients receiving palliative care involved an ICU stay, whereas 37% of
hospitalizations for patients in the usual care group involved an ICU stay. The mean relative
risk reduction for all three studies combined was 37% (SD, 23%) (Table 5).
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Trials Evaluating ICU LOS
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Interventions in the Acute Care and Outpatient Setting: RCTs—Two randomized
trials involved patient-centered interventions taking place outside of the ICU setting—one
enrolled medical inpatients 80 years old and older for an advance care planning intervention
(24) and one enrolled outpatients with a new diagnosis of life-limiting cancer for a routine
palliative care consultation (25) (Tables 2 and 4). In the first trial, Detering et al (24)
assessed the impact of advance care planning on end-of-life care. They randomized eligible
patients admitted under internal medicine, cardiology medicine, or respiratory medicine in a
large university hospital. Upon request from the authors, we were able to obtain ICU LOS
data as this outcome was not originally reported; mean LOS was 10.9 days in the control
arm and 5.3 days in the intervention arm (relative risk reduction for all patients 52%; no pvalue reported) (24). The second trial, Project Educate, Nurture, Advise Before Life Ends II,
was designed to improve palliative care for patients with advanced cancer in the outpatient
setting. This study randomized patients to a multicomponent palliative care intervention
consisting of four weekly educational sessions: ICU LOS did not differ when compared to
the control group receiving usual care (0.06 d for both groups; p = 1) (25).
Interventions in the ICU Setting: RCTs—Four RCTs evaluated the effect of ethics or
palliative care consultations in the ICU on ICU LOS; for three RCTs, the intervention was
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focused on individual patients (4, 7, 26) and one was focused at the hospital level (27). Two
separate trials conducted by Schneiderman et al (4, 7) examined the effect of routine ethics
consultation, enrolling patients in whom value-related treatment conflicts arose. A study
conducted by Andereck et al (26) also examined the effect of routine ethics consultation, but
targeted patients who were in the ICU for at least 5 days. Curtis et al (27) examined the
effect of a multifaceted quality improvement intervention to improve palliative care skills of
ICU clinicians, and they identified families as participants for outcome assessment from all
adult patients who died in the ICU.
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Both of the studies of routine ethics consultation in the ICU by Schneiderman et al (4, 7)
demonstrated significant reductions in ICU LOS for decedents in the intervention group
compared with usual care. In their single-center study, ICU LOS was 4.2 days in the
intervention group versus 13.2 days with usual care (relative risk reduction of 68%; p =
0.03) (7). The impact on LOS among decedents was lower in the larger, seven-center trial,
although still statistically significant (6.4 d for intervention vs 7.9 d in usual care; relative
risk reduction of 18%; p = 0.03) (4). Neither trial found a difference in ICU LOS for patients
who survived to hospital discharge.
By contrast, the two RCTs assessing ICU LOS as an outcome found negative results.
Andereck et al (26) failed to find any difference in ICU LOS attributable to an ethics
consultation intervention; both intervention and control patients had the same LOS (11 d; p
= 0.91). Similarly, the quality improvement intervention by Curtis et al (27) targeted at
hospitals and clinicians to integrate palliative care in the ICU did not result in a significant
decrease in LOS (5 vs 6 d, intervention vs control, respectively; p = 0.07).

Author Manuscript
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Interventions in the ICU Setting: Non-RCTs—Ten non-RCTs reported ICU LOS as a
study outcome. For seven, the interventions targeted patients and three targeted the ICU.
Eight studies reported a decrease in ICU LOS associated with a palliative care intervention.
Ahrens et al (28) evaluated the impact of a communication team consisting of a physician
and clinical nurse specialist with predefined roles aimed at addressing barriers to
communication; patients in the intervention group had shorter LOS compared with the
control group (6.1 d vs 9.5 d; relative risk reduction for all patients 36%; p < 0.01). The
study of palliative care consults for patients with global cerebral ischemia after
cardiopulmonary resuscitation using historical controls by Campbell and Guzman (29)
found a decrease in LOS (3.7 d vs 7.1 d; relative risk reduction for all patients 48%; p <
0.01). In this same study, however, patients with multisystem organ failure did not spend a
significantly longer time in the ICU when compared with historical controls receiving usual
care (p = 0.74). The following year, Campbell and Guzman (30) published another study
using historical controls and found that proactive palliative care consultation led to a
significant reduction in ICU LOS for patients with advanced dementia (3.5 d vs 6.8 d;
relative risk reduction for all patients 49%; p < 0.01). Proactive case finding involved
screening the medical ICU (MICU) census daily for any patient meeting study criteria.
Using nonrandomized controls, Dowdy et al (21) reported a 6-day reduction in LOS when
the ethics service intervened proactively after patients received more than 96 hours of
continuous mechanical ventilation (relative risk reduction for decedents 30%; no p-value
reported).
Crit Care Med. Author manuscript; available in PMC 2016 May 01.
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Four of the eight studies that found a reduction in ICU LOS were pre-post in design. Of
these, two focused on ICU system change. In a single-center study, Curtis et al (31)
evaluated the impact of a quality improvement intervention targeted to ICU personnel and
designed to integrate palliative care into the ICU; median ICU LOS was shorter in the
postimplementation period (3 d vs 4 d; relative risk reduction for all patients 19%; p = 0.01).
As described above, this difference was not observed in the follow-up multicenter cluster
RCT (27). Mosenthal et al (32) evaluated the impact of integrating, into standard care in a
trauma ICU, a structured palliative care intervention consisting of assessment of patient
prognosis and preferences, an interdisciplinary family meeting, and family bereavement
support. Among decedents, median LOS decreased from 3 days to 1 day in the
postimplementation period for relative risk reduction of 19%. Results of hypothesis testing
were not reported.
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Among the patient-focused interventions, Lilly et al (33) evaluated the impact of a
multidisciplinary family meeting held within 72 hours of admission to the MICU; they
found a reduction in median LOS in the postimplementation phase when compared with the
baseline period (3 d vs 4 d; relative risk reduction for all patients 25%; no p-value reported).
Similarly, Norton et al (22) evaluated the impact of proactive palliative care consultation for
patients admitted to the MICU and identified to be at high risk of death. This study, using a
pre/post nonequivalent control group design, found a significant reduction in ICU LOS when
compared to usual care (9 d vs 16 d; relative risk reduction for decedents 60%; p < 0.01).
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Lastly, two of these studies did not identify a difference in ICU LOS with the intervention.
Shelton et al (34) evaluated the effect of adding a full-time family support coordinator to a
surgical ICU team in a pre-post study design; no differences in LOS were observed in the
pre versus postimplementation period (11.8 d vs 11.4 d, respectively, p = 0.89). In a patienttargeted intervention, Daly et al (35) enrolled patients from five different ICUs and evaluated
the effectiveness of an intensive communication strategy in a pre-post design; there were no
significant differences in ICU LOS (13.4 d vs 14.4 d, pre vs post, respectively; p = 0.16).
Summary Statistics for Reduction in ICU Admissions and ICU LOS
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The estimates for mean relative risk reduction by intervention type are displayed in Table 5.
The mean relative risk reduction for ICU admissions associated with advance care planning
and palliative care interventions was 37% (SD, 23%). The mean relative risk reduction for
ICU LOS associated with all palliative care interventions in the ICU setting was 26% (SD,
23%). When restricting to palliative care interventions in the ICU setting that were directly
targeted at the level of individual patients, the mean relative risk reduction was 33% (SD,
23%).

DISCUSSION
Our systematic review included 22 studies—nine RCTs and 13 non-RCTs. Interventions
were diverse, populations were heterogeneous, and study designs varied. Variability in these
dimensions limited our ability to conduct a quantitative meta-analysis. Despite this, two
important trends emerged that warrant further investigation: 1) studies targeting ICU
admissions suggest that advance care planning and palliative care interventions reduce the
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number of ICU admissions for patients at high risk of death; and 2) the majority of studies
demonstrated a reduced ICU LOS with advance care planning or palliative care
interventions.
For the three studies reporting on ICU admissions, the mean relative risk reduction in
percentage of admissions seen with palliative care consultations was 37% (SD, 23%). Two of
these studies were retrospective studies that used instrumental variable (16) and propensity
score matching (17) techniques to control for potential confounding, and one study was an
RCT (23). All interventions were targeted directly at patients rather than at the system level.
These studies suggest the value of targeting the intervention to appropriate patients and that
the effect of an intervention will vary widely based on the “risk” of the target population.
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Although the trend for studies reporting ICU LOS favored decreased utilization, significant
variability was present. Among the 16 studies used to estimate the magnitude of effect, 11
reported a decrease in LOS and five demonstrated no change. There are several possible
reasons for this observed variability. First, baseline characteristics of selected patients may
have influenced results. For example, in the trial by Andereck et al (26), any adult patient in
the ICU for at least 5 days was included; the lack of restriction on baseline comorbidities or
palliative care needs and the fact that patients were already in the ICU for 5 days at
enrollment may have made it more difficult for palliative care interventions to affect LOS.
Second, intervention location differed among trials (outpatient, acute care, ICU). For
example, in the RCT conducted by Bakitas et al (25), the intervention took place in the
outpatient setting, potentially reducing the impact on ICU LOS. Third, intervention targets
varied between studies (patient vs system). For example, two of the trials reporting no
difference in LOS involved system-level interventions with patient-level outcomes, which
could potentially attenuate the effect seen on ICU LOS (27, 34). For these reasons, we
separated interventions by setting and level of the intervention target.
Even among trials that reported a decrease in LOS, the magnitude of effect varied
significantly. One explanation for this may be the alignment of the intervention target and
unit of analysis for outcomes. Although some heterogeneity is present, in general, patienttargeted interventions were more successful in reducing utilization than system-level
interventions. Perhaps attenuation of measurable impact is more likely when the intervention
takes place at a different level than the assessed outcome. Additionally, the degree of impact
of advance care planning and palliative care consultation on ICU utilization is dependent on
selecting the appropriate patients and tailoring of care to the individual patient.
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The observed variability might also be explained by differences associated with studying
decedent versus surviving subjects. Researchers should separate decedents and survivors for
analyses as implications for reduced LOS are very different for survivors versus decedents
(36).
Our review highlights limitations in existing data that make it difficult to provide precise
estimates of the effects that advance care planning and palliative care interventions have on
reducing ICU admissions and ICU LOS. Future studies are needed in order to address these
limitations and provide more accurate assessments of the magnitude of effect on resource
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utilization. For example, it was difficult to assess whether the strength (“dose”) of
interventions was sufficient to be effective and whether residual confounding or selection
bias influenced findings. Additionally, while our study questions focused on ICU utilization,
consistently reporting hospital LOS along with ICU LOS is important when assessing the
true economic effect of a reduced ICU LOS as the marginal benefit between an ICU day
saved versus a hospital day saved is a debated topic that requires further evaluation (10, 11,
37). Lastly, although data from RCTs are generally considered more robust, observational
data and non-RCT study designs may be more pragmatic in this patient population. Methods
to reduce bias such as multivariate regression techniques, propensity score matching, and
instrumental variable adjustment should be routinely used in non-RCTs. However, rigorous
randomized trials are still needed.
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Our systematic review also has several limitations. First, we acknowledge that a major
limitation of the estimates provided for reduced ICU admissions and LOS is the wide
variability. However, this is a reflection of the current literature, and future studies are
needed to increase the precision of these estimates. Second, our review may be limited by
publication bias as we did not attempt to identify unpublished studies and articles. Third, our
search strategy may have missed pertinent studies. However, because we identified the same
list of included publications in multiple databases, reference lists, and other systematic
reviews (5, 9, 38), we have considerable confidence in the accuracy and completeness of
review. Lastly, our search strategy excluded studies that focused on early palliative care
interventions with an outcome of hospital admissions if ICU admission was not a reported
outcome. We recognize that not including these studies may lead to an underestimation of
the quality of evidence for early palliative care interventions.
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Despite the limitations of the existing literature, it is possible to provide estimates of the
magnitude of effect of advance care planning and palliative care interventions on ICU
admission and ICU LOS for patients with life-limiting illness. Although the target
population and the interventions themselves are heterogeneous, assessment of the effect of
palliative care interventions across different settings and times provides greater external
validity for these estimates (39). Indeed, these compound estimates are more reliable for
future studies of the potential effects of palliative care interventions on critically ill patients,
regardless of the underlying disease or condition, than using estimates from one RCT
involving a specific population. The primary rationale for advance care planning or palliative
care interventions is to improve quality of care, ensure patients receive the care they would
choose if fully informed, and improve patient and family outcomes. However, understanding
and quantifying the potential for reduction in unwanted intensive care at the end of life may
have important clinical and economic implications for how we approach end-of-life care in
the hospital and ICU settings. These interventions aim to relieve suffering and improve
overall quality of life for patients with advanced life-limiting illnesses and their families, yet
may be difficult to implement in an effective or cost-effective way. Demonstrating that these
interventions have the potential to lead to significant cost savings may guide decisions on
resource allocation for end-of-life care in the ICU. In an era focused on cost containment
and transition from fee-for-service to the Accountable Care Organization environment,
understanding the true effect of advance care planning and palliative care interventions on

Crit Care Med. Author manuscript; available in PMC 2016 May 01.

Khandelwal et al.

Page 10

Author Manuscript

ICU resource utilization will be increasingly important, and this systematic review provides
a useful step in this direction.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Flow diagram of article inclusion. CCT = Controlled Clinical Trials, CINAHL = Cumulative
Index to Nursing and Allied Health Literature.
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